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ABSTRACT
Reoperation is the method of choice for correcting prosthetic 
paravalvular leaks. The percutaneous repair of mitral para-
valvular leaks might represent an interesting alternative in 
select cases. The present study reports two cases of mitral 
paravalvular leaks that were treated with Amplatzer™ Vascular 
Plug III guided by three-dimensional (3D) transesophageal 
echocardiography, using the percutaneous approach. The first 
case involved a 55-year-old male who had undergone five 
cardiac surgeries (aortic and mitral valve replacements) and 
presented with New York Heart Association (NYHA) class 
III heart failure and severe mitral regurgitation. The second 
case was a 76-year-old male who had undergone two aortic 
valve replacements; the last procedure was associa ted with 
mitral valve replacement, which developed into NYHA class 
IV heart failure and severe mitral regurgitation. This patient 
had several comorbidities that increased his surgical risk. The 
procedures were performed percutaneously under general 
anaesthesia, using the transseptal approach to deploy the 
plugs, which occluded the paravalvular defects successfully 
in both cases. 
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Case Report
RESUMO
Correção de Regurgitação Paravalvar Mitral  
por Via Percutânea Guiada por Ecocardiograma  
Transesofágico Tridimensional
A reoperação é o método de escolha para a correção de 
defeitos protéticos paravalvulares. A correção da regurgitação 
paravalvar mitral por via percutânea constitui uma alternativa 
interessante para casos selecionados. Relatamos dois casos com 
regurgitação paravalvar mitral, tratados por via percutânea, 
com prótese AmplatzerTM Vascular Plug III, guiados por 
ecocardiograma transesofágico tridimensional. No primeiro 
caso, o paciente, com 55 anos de idade, já havia sido sub-
metido a tratamento cirúrgico por cinco vezes (trocas valvares 
aórtica e mitral) e evoluía com insuficiência cardíaca classe 
III da New York Heart Association (NYHA) e insuficiência 
mitral grave. No segundo caso, o paciente, com 76 anos de 
idade, tinha sido submetido a troca valvar aórtica por duas 
vezes, a última associada a troca valvar mitral, e evoluía em 
insuficiência cardíaca classe IV (NYHA) e regurgitação mitral 
grave, e várias comorbidades aumentavam seu risco cirúrgico. 
Os procedimentos foram realizados por via percutânea, sob 
anestesia geral, utilizando-se a via transeptal para o implante 
dos plugs, que ocluíram os defeitos paravalvares com sucesso 
em ambos os casos.
DESCRITORES: Valva mitral. Próteses valvulares cardíacas. 
Implante de prótese de valva cardíaca. Ecografia transesofa-
giana. Ecografia tridimensional.
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A lthough surgical repair or replacement are the reference standards for treating paravalvular mitral regurgitation (mitral paravalvular leak), the high 
rates of operative morbidity and mortality are still a 
cause of great concern. The percutaneous closure of 
paravalvular leaks is an attractive method for inter-
ventional cardiologists and patients; the procedure 
eliminates the need for repeat surgeries. However, 
interventional cardiologists are reluctant to choose 
this method due to the lack of a specific device to 
perform the percutaneous closure, which is caused 
by the lack of sufficient experience of the surgical 
centres, the scarcity of data in the literature about the 
procedure because of its complexity and the relatively 
high rates of occluder displacement. This study reports 
two cases of successful prosthesis implant using Am-
platzerTM Vascular Plug III (AGA Medical – Plymouth, 
USA) guided by three-dimensional (3D) transesophageal 
echocardiography.
CASE REPORT
Clinical case 1
A 55-year-old male patient presented with rheumatic 
valvular disease. The patient underwent five cardiac 
surgeries (the first in 1974, at age 19) with replace-
ment of the mitral and aortic valves with a mechanical 
Starr-Edwards prosthesis. In May of 1975, he underwent 
new mitral and aortic replacement, and another mitral 
prosthesis replacement was necessary in the same 
year because of prosthesis dysfunction. In 1979, he 
underwent a new mitral and aortic replacement with 
a mechanical Starr-Edwards prosthesis because of the 
dysfunction of the previous device.
He remained oligosymptomatic and underwent clini-
cal follow-up until 2001, when he presented dyspnea 
on moderate exertion in atrial fibrillation, with severe 
stenosis in both prostheses, in addition to ascending 
aortic aneurysm (60 mm in diameter). In 2001, at age 
46, he underwent his fifth heart surgery with implan-
tation of mitral and aortic double-disc mechanical 
prostheses in conjunction with a replacement of the 
ascending aorta segment with a tubular prosthesis and 
reimplantation of the coronary arteries.
In 2006, during the clinical follow-up, the patient 
underwent a two-dimensional (2D) transthoracic echo-
cardiography, which showed severe mitral paravalvular 
regurgitation, but the patient refused further surgical 
treatment. Since then, he has had several hospitalisa-
tions for heart failure, aggravated by anemia (hemolysis). 
The patient, however, maintained his decision not to 
undergo another cardiac surgery and was always dis-
charged with optimised drug therapy.
In 2011, the 2D transthoracic echocardiography 
showed mechanical prostheses with normal disc 
excursion and preserved left ventricular systolic func-
tion despite the severe paravalvular mitral regurgitation, 
moderate right ventricular dysfunction, and pulmonary 
artery systolic pressure estimated at 90  mmHg. In 
that same year, the team proposed to the patient a 
percutaneous correction of the periprosthetic defect, 
which was performed on July 6, 2011 (Figure 1). The 
procedure was performed under general anaesthesia 
and was initiated by puncturing the right femoral vein 
and the left femoral artery with 7 F and 6 F introduc-
ers, respectively, followed by the administration of 
a 100  U/kg dose of unfractionated heparin. Subse-
quently, a transseptal puncture was performed using 
a Brockenbrough needle and an 8  F Mullins sheath. 
A hydrophilic guidewire was introduced through the 
Mullins sheath with a 0.035-inch Radiofocus Terumo® 
260 cm angle tip (Terumo Medical Co. – Tokyo, Japan), 
maintained in the left atrium. Using this guidewire, the 
Mullins sheath was exchanged for a Fu Star® sheath 
(Lifetech Scientific – Shenzhen, China), through which 
the paravalvular defect was found and the 0.035-inch 
Radiofocus Terumo® 260 cm angle tip guide wire was 
steered past the defect with the aid of 3D transesopha-
geal echocardiography. The Fu Star® Lifetech sheath 
was exchanged with a therapeutic Multipurpose 7  F 
catheter (Johnson & Johnson Co. – Miami, FL, USA), 
which was guided past the paravalvular defect and 
through which another 0.035-inch Radiofocus Terumo® 
260 cm angle tip guide wire was introduced. This cath-
eter was removed and two Multipurpose 7 F catheters 
were introduced separately through the two guide 
wires that were guided past the paravalvular orifice. 
Then, two AmplatzerTM Vascular Plug III (numbers 10 
and 8) prostheses were implanted through the 7  F 
multipurpose catheters with continuous monitoring by 
3D transesophageal echocardiography, which guided 
the correct prosthesis positioning and release. At the 
end, the disappearance of the paravalvular defect 
was demonstrated. There were no complications dur-
ing the procedure. The patient was extubated in the 
catheterisation laboratory and observed for 2 hours 
before discharged to the infirmary.
Clinical Case 2 
The second case was a 76-year-old male patient 
with a history of systemic arterial hypertension, 
chronic renal failure, and stroke. He was diagnosed 
with hepatitis B in the late posto perative period 
of biological aortic valve replacement number 23, 
which was performed in January of 2011. In April 
of 2011, he developed infective endocarditis from 
coagulase-negative Staphylococcus aureus and was 
treated with vancomycin, gentamicin, and rifampicin. 
The biological aortic prosthesis was exchanged for a 
new bioprosthesis (number 27) in conjunction with 
a mitral valve replacement and tricuspid plasty, in 
addition to reducing the aortoplasty of the ascending 
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portion of its calibre. He was discharged after two 
months of hospitalisation.
The patient developed dyspnea upon exertion, 
and a 2D transthoracic echocardiography was per-
formed on November 18, 2011, which showed an 
ejection fraction of 60%, aortic bioprosthesis with thin 
leaflets without regurgitation (valve area of 1.7  cm2 
and maximum systolic gradients of 18 mmHg, mean 
10  mmHg), mitral bioprosthesis with thin leaflets, 
preserved opening and mobility, and severe anterior 
paravalvular regurgitation, with maximum diastolic 
gradients of 13  mmHg (mean 7  mmHg) and slight 
tricuspid regurgitation. As a result of relevant symptoms 
and high surgical risk, a percutaneous closure of the 
mitral paravalvular defect was indicated and performed 
on November 30, 2011 (Figure 2). The procedure was 
performed under general anaes thesia and was initiated 
by puncturing the right femoral vein and the left 
femoral artery with 7 F and 6 F introducers, respec-
tively, followed by administering a dose of 100 U/kg 
of unfractionated heparin. Left ventriculography was 
performed in the right anterior oblique projection, 
which showed increased end-diastolic volume and 
moderate inferobasal hypokinesia, as well as mild 
hypokinesia in the other left ventricular walls. Sub-
sequently, a transseptal puncture was performed with 
a Brockenbrough needle and an 8  F Mullins sheath. 
The paravalvular orifice was located and a 260-cm, 
0.035-inch extra-stiff guidewire was introduced past it 
together with a 3.5, 6 F Judkins right catheter curve 
(Johnson & Johnson Co. – Miami, FL, USA) and another 
similar guide with a Multipurpose 7 F catheter, with 
the aid of 3D transesophageal echocardiography. Then, 
two AmplatzerTM Vascular Plug III (numbers 10-5 and 
4-2) prostheses were implanted with the help of 3D 
transesophageal echocardiography, which was used to 
guide the correct positioning of the prosthesis (Figure 
3). At the end of procedure, it was demonstrated that 
the paravalvular defect had completely disappeared 
(Figure 4). There were no complications during the 
procedure. The patient was extubated in the cathe-
terisation laboratory and kept under observation for 
two hours, before discharge to the infirmary.
The transesophageal echocardiography, which was 
performed two days after the procedure, showed mitral 
bioprosthesis with thin leaflets, preserved opening and 
mobility, and no paravalvular regurgitation. The puncture 
site showed no bleeding or bruising. The patient was 
asymptomatic upon discharge and was asked to return 
for follow-up at the outpatient valve disease clinic.
DISCUSSION
Paravalvular regurgitation after prosthetic valve 
implantation is a complication that occurs in 2.5% 
to 5% of patients who are referred for surgical valve 
replacement.1
Figure 1 – In A, catheters in the left ventricle after moving past the mitral paravalvular orifice. In B, the positioning of the prostheses, with guide-
wire in the left ventricle. In C, placement of the prostheses, starting their release. In D, the release of the prostheses. In E and F, the final result.
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These regurgitations occur as a result of prosthesis-
annulus suture dehiscence and vary in size. A small 
regurgitation may be asymptomatic or cause hemolysis, 
whereas large regurgitations can cause severe hemo-
dynamic alterations and heart failure.2 In significant 
paravalvular regurgitations, percutaneous treatment can 
constitute an alternative to surgery for patients with 
high perioperative risk, particularly considering that a 
new surgery is associated with mortality rates of ap-
proximately 16%.3,4 However, significant regurgitation 
after percutaneous treatment is sometimes observed, and 
further intervention is required in up to 40% of cases.4,5 
Recently, new techniques and devices for percuta-
neous closure of paravalvular regurgitations have been 
Figure 2 – In A, ventriculography in right anterior oblique view, showing mitral paravalvular regurgitation. In B, catheters in the left ventricle after 
moving past the mitral paravalvular orifice to start the prosthesis positioning. In C, the positioning of the prostheses and their release. In D, the final 
result.
developed, although most do not specifically address the 
anatomical peculiarities of these regurgitations. Based 
on this discussion, it is necessary to develop specific 
devices for closing paravalvular regurgitations.4 Coils are 
usually used in small defects, patent ductus arteriosus 
occlusion devices for moderate defects, and septal 
defect occlusion devices for large defects.1,3 The ideal 
device should be suitable to seal the defect without 
causing hemolysis and thrombus formation and their 
consequent embolic complications.4 
The 3D transesophageal echocar dio graphy performed 
before the procedure is essential to evaluate the size, 
location, and shape of the regurgitation. All such infor-
mation is essential for choosing the most appropriate 
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Figure 3 – Three-dimensional transesophageal echocardiogram images obtained sequentially during the procedure. In A, the periprosthetic defect (green 
arrow), which is located at the 3 o’clock position with the heart in anatomical position. In B, the unsuccessful attempt to go past the periprosthetic 
defect with the catheter, which actually passed through the central orifice of the prosthesis. In C, the catheter after going past the periprosthetic 
defect (red arrow). In D, two AmplatzerTM Vascular Plug III devices are already released, closing the periprosthetic defect (yellow arrows).
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Figure 4 – Conventional transesophageal echocardiography images. In A, the periprosthetic defect with regurgitation into the left atrium. In B, after 
the AmplatzerTM Vascular Plug III (green arrow) device implantation, which is located between the prosthetic ring and the atrial wall, defect occlu-
sion with the disappearance of periprosthetic regurgitation. LA = left atrium.
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model of the device and to better plan the occlusion 
strategy. The 3D transesophageal echocardiography, 
which is also performed during the procedure, helps 
to obtain spatial resolution; therefore, it contributes to 
improved success rates and provides better positioning 
of the guide wires and devices related to paravalvular 
regurgitation. This improvement is attributed to the pos-
sibility of obtai ning images of the prosthesis through 
the left atrium, which decreases the acoustic shadow 
generated by the prosthesis.1
The percutaneous closure of paravalvular regur-
gitations is one of the most challenging procedures 
currently performed by interventional cardiologists. 
Experience suggests that using 3D echocardiography 
can improve the indices of immediate procedural 
technical success. Clinical success in the long term, 
however, is influenced by the limitations associated 
with the use of currently existing devices, which jus-
tifies the need to develop specific devices to close 
paravalvular regurgitations.4 
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